OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
February 28, 2022
Clinical and industry leaders share their perspectives on the importance of collaboration in developing treatments for rare diseases.
January 28, 2022
A multitude of promising new investigative therapies are on the horizon for inherited retinal disease.
January 14, 2022
Exciting new therapies for sickle cell disease are on the horizon. We explored some of the most promising investigational therapies in recognition of National Blood Donor Month.
April 30, 2021
The study presented at the 2021 AAN Meeting follows the complete response letter issued by the FDA to Acadia Pharmaceuticals due to deficiencies in their sNDA.